Article
Dissemination of clinical isolates of Klebsiella oxytoca harboring CMY-31, VIM-1, and a New OXY-2-type variant in the community.
Antimicrobial agents and chemotherapy - 1 Jul 2011
Tsakris Athanassios, Poulou Aggeliki, Markou Fani, Pitiriga Vassiliki, Piperaki Evangelia-Theophano, Kristo Ioulia, Pournaras Spyros
Abstract excerpt
The aim of the present study was to investigate the epidemiological link of multidrug-resistant Klebsiella oxytoca isolates causing community-onset infections among patients attending our outpatient department and to investigate the underlying resistance mechanisms. The isolates were tested by agar dilution MICs, phenotypic carbapenemase testing, enterobacterial repetitive intergenic consensus-PCR, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
